| __timestamp | Celldex Therapeutics, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 15635076 |
| Thursday, January 1, 2015 | 100171000 | 23943601 |
| Friday, January 1, 2016 | 102726000 | 23689111 |
| Sunday, January 1, 2017 | 96171000 | 41006114 |
| Monday, January 1, 2018 | 66449000 | 51379106 |
| Tuesday, January 1, 2019 | 42672000 | 32705593 |
| Wednesday, January 1, 2020 | 42534000 | 53274000 |
| Friday, January 1, 2021 | 53311000 | 85352000 |
| Saturday, January 1, 2022 | 82258000 | 51999000 |
| Sunday, January 1, 2023 | 118011000 | 59471000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Celldex Therapeutics, Inc. and Summit Therapeutics Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, Celldex consistently outpaced Summit in R&D spending, with an average annual investment of approximately $81 million, nearly double Summit's $44 million. Notably, in 2023, Celldex's R&D expenses surged to their highest, marking a 40% increase from 2022, while Summit's spending grew by 14%. This trend underscores Celldex's commitment to innovation, even as Summit shows steady growth. As these companies continue to push the boundaries of medical science, their financial dedication to R&D highlights the critical role of investment in shaping the future of healthcare.
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.